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Individuals with both type 1 and type 2 diabetes mellitus (DM)
are known to be at high risk for developing coronary artery dis-
ease (CAD). The risk is two to three times greater in those with
DM compared with those without, and is especially high in women
with DM. An additional problem in individuals with DM is that,
even with severe underlying CAD, many individuals may have
atypical symptoms or be totally asymptomatic, a condition re-
ferred to as silent or asymptomatic myocardial ischemia.
Asymptomatic myocardial ischemia is frequently found in indi-
viduals with known CAD, even in individuals without DM, and is
associated with a poorer long term prognosis. The Asymptomatic
Cardiac Ischemia Pilot Study demonstrated that asymptomatic
ischemia was associated with three times the risk of nonfatal myo-
cardial infarction and six times the risk of myocardial infarction or
death.
However, asymptomatic myocardial infarction also occurs in a
substantial number of individuals without known CAD, particu-
larly those with DM. These individuals have not been diagnosed
with CAD and do not have the beneﬁt of anti-anginal therapies
or aggressive CAD risk reduction. In the recent Detection of
Ischemia in Asymptomatic Diabetics (DIAD) study, 21.6% of old-
er adults with type 2 DM, none of whom had any clinical evidence
of CAD, had evidence of myocardial ischemia on single photon
emission computed tomography (SPECT) myocardial perfusion
imaging. This ﬁnding was consistent with earlier studies in the
population with type 2 DM.
In asymptomatic patients with either type 1 or type 2 DM,
asymptomatic myocardial ischemia is also associated with major
cardiac events. Importantly, the presence of cardiac autonomic
neuropathy, long theorized to have a role in asymptomatic
CAD, substantially increases the risk of subsequent cardiac events,
with those individuals with both asymptomatic myocardial ische-
mia and cardiac autonomic neuropathy, being at highest risk.
doi:10.1016/j.jsha.2010.02.339
SHA 65. Unacceptable resuscitation outcome – Is there a theory–
practice gap
Mr. Manny Mortell, Nurse Specialist a, King Abdulaziz b
a Cardiac Critical Care
b Cardiac Centre, NGHA
Objectives: The goal of resuscitation interventions for a victim
in respiratory or cardiac arrest is to support and restore effective
oxygenation, ventilation and circulation. During these resuscita-
tion interventions, the primary objective is to prevent or limit cere-
bral ischemia and therefore, cerebral anoxia. Despite brilliant
scientiﬁc advances over the last decade, contemporary resuscita-
tion outcomes remain unacceptably poor.
Methods: Resuscitation theory and practice has been subject to
the most intense scrutiny, hence the rationale for generation of
guideline recommendations by the International Liaison Commit-
tee on Resuscitation (ILCOR) and the AmericanHeart Association
(AHA). The primary objective for the resuscitation recommenda-
tions was to narrow the well documented gap between theory and
practice in an effort to seek enhanced outcomes such increased post
resuscitation survival and signiﬁcant decrease in neurological mor-
bidity. However, current survival statistics vary from 6.4% to 25%
for out of hospital and 0–29% in hospital cardiac arrests.
Results: Theory and practice are major components for any po-
sitive outcome, however, there is a third component, which has not
been considered or addressed, and it concerns ethics. The issue of
concern identiﬁed, is that life support providers do possess evi-
dence based knowledge, but they do not practice. The question,
why is there non-compliance?
Conclusion: Contemporary healthcare incorporates latest evi-
dence based education, which we call theory, and combines this
with dynamic psycho-motor skills – which we call practice, in or-
der to provide high quality care with positive outcomes. The miss-
ing vital ingredient is ethics.
Tracks: Cardiac Nursing.
doi:10.1016/j.jsha.2010.02.340
SHA 66. Is there a real risk to operate the elderly patient above 80
years old, for CABG
Mr. Georges Tedy
Chief Department of Cardiac Surgery, Clinique Du Levant
Objectives: Between 2007 and 2009, 615 patients underwent
CABG in our institution, 65 of them have more than 80 years
old (10.5%), 52% male, 64% suffered from hypertension, 22%
from diabetes, 40% tobacco, the mean EF of the left ventricle
was about 50%, 78% of the patients underwent isolated CABG.
Methods: Twenty percentage underwent combined surgery for
valve replacement, and 2% for carotid endarteriectomy. Thirty
percentage only of our patients proﬁt from offpump surgery,
34% need the use of inotrops in the immediate postoperative care,
75% of them had been transfused with more than 02 units of
blood, 33% of them presented an atrial ﬁbrillation, 40% beneﬁt
from a fast track extubation inferior to 6 h after there arrival to
the CSU, 5 patients (7%) had been re-operated for bleeding,
and 5 others need a prolonged respiratory assistance, 2 patients
died (3%).
Results: The mean duration of CSU stay was 2 days and the
total in hospital stay was 7 days.
Conclusion: Our study shows that CABG in the elderly (>80
years) can be performed with a low risk of mortality and morbid-
ity, even if it is done on pump.
Tracks: Cardiovascular Surgery.
doi:10.1016/j.jsha.2010.02.341
SHA 67. Accuracy of surgical scores for prediction of operative
mortality in patients undergoing transapical aortic valve
implantation?
Dr. Feras H. Khaliel
Fellow Cardio Vascular Surgeon, ICM
Objectives: Risk assessment for patients undergoing transapical
aortic valve implantation (TAVI) is currently performed with the
EuroSCORE and STS-PROM risk algorithms. None of these
scores were designed for a TAVI population. To demonstrate
the accuracy, both scores were compared to the real outcome in
patients undergoing TAVI.
Methods: Thirty six patients underwent TAVI using the Ed-
wards Sapien bioprosthesis between September 2007 and June
2009 due to contraindications of conventional surgery and/or high
operative risk. Mean age was 81 ± 9.8 years and 40% were fe-
male. Mean STS and EuroSCORE were 30.9% (SE = 2.2) and
22.3% (SE = 2.1), respectively. Multiple variables were used in
the calculation of the EuroScore and the STS-PROM algorithms
including chronic lung disease (22, 2%), renal failure (33, 3%),
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cancer (25%), neurological dysfunction (11, 1%), peripheral arte-
riopathy (66.7%), previous cardiac surgery (41, 6%), diabetes (27,
7%), severe pulmonary hypertension higher than 60 mmHg (16,
7%), moderate LV EF more than 50% (50, 05%), and LVEF less
than 30% (19, 4%). Certain variables do not ﬁgure in the algo-
rithm as porcelain aorta (36, 1%) and mediastinal irradiation (5,
5%). Observed in-hospital death was 18.2%. The actual and pre-
dicted mortality were compared.
Results: Operative mortality (30 days) = 5 patients (15.6%). An
additional 5 patients (15.6%) died during the follow-up study period
of 587days (mean 324 ± 164). Overall mortality = 10 patients
(31.2%). Both the STS and EuroSCORE failed to demonstrate sig-
niﬁcant correlation with predicted operative mortality (HR= 0.97,
[95% CI 0.98–1.06] p= 0.536 and HR= 0.99, [95% CI 0.90–1.08]
p= 0.818, respectively). The STS algorithm seemsmore accurate in
estimating the operative mortality in TAVI patients.
Conclusion: Current surgical scores correlate poorly with the
observed outcome. Reﬁning these scores for high risk patients
requiring aortic valve surgery may improve patient selection for
TAVI.
Tracks: Cardiovascular Surgery.
doi:10.1016/j.jsha.2010.02.343
SHA 68. Transapical aortic valve implantation
Dr. Feras H. Khaliel a, Dr. Nawwar Al-attar b
a Fellow Cardiovascular Surgeon, ICM
b Consultant Cardiovascular Surgeon, Bichat Hospital
Objectives: Aortic valve replacement (AVR) is indicated in se-
vere symptomatic AS, but limitation can be present in doing the
golden standard. Hereby, the presence of another minimal inva-
sive technique (TVAI) will bypasses these limitations in high risk
patients.
Methods: The total experience with TAVI is well over 600 pa-
tients. In our centre, 50 patients were consecutively treated with
TAVI with a mean age of 83 ± 6 years, and a predicted surgical
mortality of 28 ± 14% and 16 ± 7% using the EuroSCORE and
STS score, respectively. Thirty-ﬁve patients were treated via the
TF and 15 via the TA approach using the Edwards SAPIEN valve.
Results: The implantation success rate of the transapical proce-
dure was 93%, survival after 6 months is around 70%. TA pa-
tients had a 30 day mortality of 10.3%. The stroke rate was
2.4% and pacemaker implantation rate was 6.7%. Vascular com-
plication rate <3%. In our centre comordities were more frequent
in TA patients. Successful implantation was 85.7% and 100% in
the TF and TA group, respectively. Stroke in the TF group was
(6%) and non in the TA, while mortality rate was 8% and 27%,
respectively.
Conclusion: Although early results of TAVI are encouraging,
this procedure has a potential for serious complications. Careful
selection of high risk patients are demanded for better results with
lower complication rate.
Tracks: Adult Cardiology.
doi:10.1016/j.jsha.2010.02.344
SHA 69. Monitoring and improving service in cardiac disease
management clinics
Dr. Mohammed Bdeir
Head of Cardiac Disease Management, KAMC
Objectives: Evaluate and improve the timeliness of service given
to patients in nurse directed outpatient cardiac disease manage-
ment clinics. As cardiac centers provide acute care that prolongs
life, there is an increasing responsibility to provide quality cardiac
outpatient care. An increasing number of centers are providing
tertiary care; however, there has not been a corresponding increase
in the availability and quality of outpatient care. We are in the
process of evaluating this gap in care at our institution. This study
focuses on waiting time and time spent with the clinical nurse spe-
cialist in our Congestive Heart Failure (CHF) and Atherosclerosis
disease management clinics.
Methods: This study is based on data on visits for the month of
October 2009.
Results: We were pleased to ﬁnd acceptable waiting times for
both the CHF and Atherosclerosis Clinics 24 (range 10–32) and
24 (range 13–30) min, respectively. Work will continue in an effort
to improve on this performance. What was somewhat unexpected,
however, was the longer average time spent with Atherosclerosis
patients as compared to CHF patients 41 (range 38–45) vs. 38
(range 31–44) min. It is important to note that the time slot for
each visit is 30 min. An average time of 60 (range 22–80) min,
was spent with new patients admitted to the Atherosclerosis and
CHF clinics. Remarkably service to walk-in patients was better
than expected. Average waiting time was 32 min (range 23–
58 min). Time spent with nurses averaged 29.5 min (range 22–
45 min). Currently patients attending the clinic for medication re-
ﬁlls are not tracked; however, this workload will be monitored and
evaluated in the future.
Conclusion: In summary this study suggests that the allocated
time for patient visits for the Atherosclerosis and CHF clinics
may need to be increased to better accommodate the needs of pa-
tients. This information is important for those centers planning
disease management facilities in the region as it will help them
in evaluating the number of clinics and staff they will need.
Tracks: Adult Cardiology.
doi:10.1016/j.jsha.2010.02.345
SHA 70. Truncus arteriosus repair: Short and midterm outcome and
the need for reintervention
Muna I. Ismail, Ali A. AlAkhfash, Riyadh M. Abu-Sulaiman,
Abdulaziz Al Khaldi, Mohamed S. Kabbani, Hani K. Najm
King Abdulaziz Cardiac Center, King Abdulaziz Medical City,
Riyadh, Saudi Arabia
Introduction: Truncus arteriosus (TA) is an uncommon congen-
ital cardiac malformation, accounting for approximately 1.2% of
all congenital heart malformations. Repair of TA is associated
with a signiﬁcant morbidity and mortality. Reintervention after
TA repair is a concern in the mid and long-term follow-up.
Objectives: The aim of the study is to evaluate our experience
with TA repair looking for short and midterm outcome and the
need for reintervention.
Methodology: Databases and chart review analysis of all patients
who underwent TA repair at our centre during the period from
December 2001 till October 2008 was conducted. Truncal valve
morphology with or without truncal valve stenosis and/or insufﬁ-
ciency were recorded (pre and post-surgery). The requirement for
reintervention, morbidity, and mortality were also reviewed.
Results: From a total of 25 patients with TA, 21 fulﬁll the
inclusion criteria. Eleven (52%) of them were females. Sixteen
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